Core Viewpoint - The Guangdong Province has launched a comprehensive policy to support the high-quality development of the medical institution preparation industry, marking the first specialized policy in the nation for this sector [1][2] Group 1: Policy Implementation - The policy is part of the implementation of the national comprehensive reform demonstration zone for traditional Chinese medicine, aiming to leverage Guangzhou's medical resource advantages and establish a biopharmaceutical innovation "super node" [1] - The initiative is designed to enhance the collaborative development of the preparation industry across the province by utilizing Guangzhou's strengths in medical resources, industrial foundation, and market scale [1] Group 2: Challenges in the Industry - The medical institution preparation industry faces multiple obstacles, including low automation levels in production, insufficient detection accuracy, and reliance on manual operations that can lead to contamination [1] - Regulatory challenges arise from limited resources that hinder comprehensive sampling inspections and an incomplete adverse reaction monitoring system [1] - Cost issues are exacerbated by significant increases in the prices of traditional Chinese medicinal materials, while the pricing of preparations is restricted, leading to "price inversion" that halts some product varieties [1] Group 3: Specific Measures - The new policy includes 19 specific measures across five key areas: accelerating R&D transformation, restructuring the manufacturing system, expanding resource capacity, enhancing service levels, and cultivating a financial ecosystem [2] - This framework aims to provide a model for Guangdong to pioneer and test innovative practices in the medical preparation industry [2]

Core Viewpoint - The implementation of the first national policy for the development of the medical institution preparation industry in Guangzhou marks a significant step towards enhancing the quality and efficiency of this sector in China [1][2]. Group 1: Policy Overview - The Guangdong provincial government has introduced specific measures to support the high-quality development of the medical institution preparation industry, which is seen as crucial for the innovation of traditional Chinese medicine and addressing grassroots medication challenges [1]. - The new policy includes 19 specific measures focusing on five key areas: accelerating research and development transformation, restructuring the manufacturing system, expanding resource pools, enhancing service capabilities, and cultivating a financial ecosystem [1][2]. Group 2: Challenges and Solutions - Current challenges in the medical institution preparation industry include low automation in production, insufficient testing accuracy, rising prices of medicinal materials, limited pricing flexibility for preparations, a shortage of professional talent, and difficulties in process inheritance [1]. - The policy aims to address these challenges by proposing a pathway from traditional formulas to innovative drugs, providing policy and financial support across the entire chain from research to clinical trials and production [2]. Group 3: Implementation and Impact - The policy will initially be implemented in Guangzhou, which accounts for a quarter of Guangdong's pharmaceutical manufacturing industry and over 60% of the province's medical institution preparation revenue [2]. - The measures are expected to create a replicable and scalable model for the entire province, promoting collaborative development within the preparation industry [2].